Apeikon Therapeutics
PrivateLast Round
Seed
Mar 31, 2023
Total Funding Raised
$1.37M
Company Overview
Apeikon Therapeutics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in March 2023.
Apeikon Therapeutics is a biotechnology company that develops image-guided, activatable nanoparticle technology for the targeted delivery of anti-cancer drugs to tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Imaging, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apeikon Therapeutics Comparables
Compare Apeikon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Advanced Microbubbles, Inc. | 77% | |
| OxSonics Therapeutics | 77% | |
| Exact Therapeutics AS | 76% |
For institutional investors. Book with your work email.
Apeikon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 31, 2023 | ||||
| Angel | Nov 30, 2022 | ||||
| Grant | Mar 1, 2022 |
For institutional investors. Book with your work email.
Apeikon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| SFC Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 30, 2022
King's College London participated in the round.
- Mar 1, 2022
$1.19M grant awarded by Innovate UK
For institutional investors. Book with your work email.
Apeikon Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Apeikon Therapeutics's valuation, stock price, and market status.
Is Apeikon Therapeutics a public or private company?
Apeikon Therapeutics is a private company.
What is the current stock price of Apeikon Therapeutics?
Apeikon Therapeutics is a private company, so its shares have no public market price. Caplight tracks Apeikon Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Apeikon Therapeutics worth (valuation)?
Valuation information for Apeikon Therapeutics is not publicly available.
Can I buy Apeikon Therapeutics stock?
Apeikon Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Apeikon Therapeutics's last funding round?
Apeikon Therapeutics's most recent funding round was Seed on March 31, 2023.
Who are the main investors in Apeikon Therapeutics?
Key investors in Apeikon Therapeutics include Innovate UK, SFC Capital.
Will Apeikon Therapeutics IPO soon?
No public IPO plans have been announced for Apeikon Therapeutics.
How can I track Apeikon Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Apeikon Therapeutics's shares on secondary markets.